Earendil Labs Raises Nearly $800 Million for AI-Assisted Development of Biologics
Key Highlights
- Earendil Labs raised $787 million to fund AI-driven biologics research and development.
- The company’s platform has already produced more than 40 therapeutic programs.
- Funding will support pipeline growth, team expansion, and strategic partnerships, including collaborations with Sanofi.
- Focus areas include autoimmune and inflammatory diseases with unmet treatment needs.
- The company aims to accelerate clinical milestones and deliver innovative biologics globally.



